Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Genetics and therapeutic intervention].

T Brousseau1

  • 1INSERM CJF 95/05, Institut Pasteur de Lille.

Annales Pharmaceutiques Francaises
|March 12, 1999
PubMed
Summary
This summary is machine-generated.

Understanding genetic factors in metabolic diseases can identify individual susceptibility. This knowledge supports revising classifications and optimizing treatments through pharmacogenetics for better patient outcomes.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Allelic variation in the promoter region of the LDL receptor gene: analysis of an African-specific variant in the FP2 cis-acting regulatory element.

Molecular and cellular probes·2003
Same author

Blood lipid concentrations and risk of myocardial infarction.

Lancet (London, England)·2001
Same author

Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations-the ECTIM study.

Human molecular genetics·1999
Same author

Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study.

Journal of epidemiology and community health·1999
Same author

Early effect of ApoE-epsilon 4 allele on cognitive results in a group of highly performing subjects: the EVA study. Etude sur le Vieillissement Artériel.

Neuroscience letters·1996
Same author

Familial defective apolipoprotein B-100 and myocardial infarction. The ECTIM study. Etude Cas-Témoins de l'Infarctus du Myocarde.

Atherosclerosis·1995

Area of Science:

  • Molecular mechanisms of metabolic diseases
  • Genetic inheritance and disease susceptibility

Context:

  • Current disease classifications rely on phenotypic examination, leading to patient heterogeneity.
  • Individual variability in therapeutic response is significant.

Purpose:

  • To highlight the importance of genetic factors in metabolic diseases.
  • To advocate for revising disease classifications and diagnostics.
  • To introduce pharmacogenetics for personalized medicine.

Summary:

  • Genetic mutations influence individual susceptibility to metabolic diseases.
  • Incorporating genetic insights can refine disease classification and diagnostics.
  • Pharmacogenetics enables tailored therapeutic strategies for homogeneous patient groups.

Related Experiment Videos

Impact:

  • Improved understanding of metabolic disease etiology.
  • More precise diagnostic and classification methods.
  • Optimized therapeutic interventions through personalized pharmacogenetics.